Singapore markets close in 3 hours 19 minutes
Straits Times Index
3,265.25 +11.46 (+0.35%) Nikkei
29,192.20 +323.29 (+1.12%) Hang Seng
19,987.10 +156.58 (+0.79%) FTSE 100
7,536.06 +26.91 (+0.36%) BTC-USD
24,122.06 +219.80 (+0.92%) CMC Crypto 200
575.80 +3.89 (+0.68%)
PFE Jan 2023 45.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 01:21PM EDT. Market open.
| Previous close | 1.5700 |
| Open | 1.6300 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 45.00 |
| Expiry date | 2023-01-20 |
| Day's range | 1.5700 - 1.6500 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Zacks
Novavax (NVAX) Seeks FDA Authorization for COVID-19 Booster Dose
Novavax (NVAX) seeks label expansion from the FDA for its COVID-19 vaccine as a booster dose in adults. The vaccine is authorized as a primary two-dose regimen in adults.
- Yahoo Finance Video
UK approves COVID vaccine that targets Omicron subvariants
Yahoo Finance reporter Anjalee Khemlani details how the U.K. has approved a vaccine that targets both the original and omicron variants of the coronavirus.
- Motley Fool
1 Hot Growth Stock to Buy, and 1 to Avoid (For Now)
On that note, Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) worked together to develop and commercialize their coronavirus vaccine, Comirnaty. In BioNTech's second quarter, practically 100% of its product sales, totaling around $3.3 billion, were attributable to its share of jab revenue.
© 2022 Yahoo. All rights reserved.
